Disc Medicine (IRON) Stock Price & Analysis

IRON$80.00-3.23 -3.88%
BiotechnologyGrowth Stock
Compare
Market cap$3.07BEnterprise value$3.31BRevenue (TTM)$0Market position—

Score

66
Bullish
Value
52
Quality
47
Growth
98

AI Analysis

Snapshot

Disc Medicine is a growth-led story right now — Growth 98/100 is the pillar doing the heavy lifting (overall 66/100) in Biotechnology. In Biotechnology, that score mix is usable but not one-dimensional. Street targets still imply ~59% upside.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

52
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

98
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

47
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Disc Medicine, Inc. (IRON) last printed $80.00. Equity value is $3.07B. Trailing earnings multiple —. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

202020212022202320242025
$0.00$0.00$0.00$0.00$0.00$0.00

About

Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.

Disc Medicine (IRON) Stock Price & Analysis

IRON price $80.00 -3.23 -3.88%

Ticker
IRON
Price
$80.00
Change
-3.23 -3.88%
Market cap
$3.07B
Forward P/E
23.73
Dividend yield
0.00%
Beta
2.01
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
66
Value
52
Quality
47
Growth
98

Stocklytics score rationale: value 52, quality 47, growth 98.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener